If you're investing with a 10-year horizon, the game changes.
Short-term earnings beats, monthly volatility, and broker upgrades become far less important.
What really matters instead is whether a business has a long runway, structural tailwinds, and the ability to compound earnings over many years.
With that in mind, listed below are three Australian stocks that could be worth buying and holding right through to 2036 (and probably beyond). They are as follows:
Image source: Getty Images
Life360 Inc. (ASX: 360)
The first Australian stock for investors to consider for the long term is Life360.
It operates a global family safety platform that combines location sharing, emergency services, and digital protection tools. While the company is nearing 100 million monthly active users (MAUs), monetisation is still developing. That creates a rare combination of scale and optionality.
Over the next decade, the opportunity lies in deepening engagement. As Life360 layers in more services such as identity protection, roadside assistance, and insurance-related offerings, its average revenue per user (ARPU) metric could rise meaningfully.
Overall, a business with a large installed base and expanding revenue streams has the potential to look significantly larger in 2036 than it does today.
Megaport Ltd (ASX: MP1)
Another Australian stock with long-term appeal is Megaport.
Megaport provides on-demand connectivity between data centres, cloud providers, and enterprise networks. As organisations increasingly operate across multiple cloud platforms and geographies, network complexity rises. Megaport's software-defined platform is designed to simplify that complexity.
Over a 10-year period, digital transformation is unlikely to slow. If anything, data usage, cloud adoption, and AI-driven workloads should increase demand for flexible connectivity solutions. This bodes well for Megaport.
In addition, its opportunity is tied less to any single technology trend and more to the broader expansion of global digital infrastructure.
ResMed Inc. (ASX: RMD)
A final Australian stock that could be a top buy and hold option until 2036 is ResMed.
ResMed sits at the heart of healthcare, demographics, and technology. Rising awareness of sleep apnoea and chronic respiratory conditions continues to expand its addressable market, which stands at over 1 billion people.
Beyond sleep apnoea devices, ResMed has been building a growing software ecosystem that connects patients, healthcare providers, and insurers. This recurring data-driven model strengthens customer relationships and creates long-term stickiness.
With ageing populations across developed markets and increasing healthcare digitisation, ResMed's growth drivers are likely to remain in place for many years.
